Cervical cancer represents a huge burden of non-infectious disease globally. It is the second commonest cancer in the female. There are over half a million deaths recorded every year as result of cervical cancer. The aetiological agent implicated in this disease is the human Papillomavirus. The high-risk human papillomavirus has been mostly implicated. The commonest high-risk human papillomavirus implicated in cervical cancer worldwide is type 16 and 18. The viral infection of the uterine cervical epithelium initially causes the development of precancerous lesions referred to as cervical intraepithelial lesions/squamous intraepithelial lesions which take many years to progress into cancer. The Papanicoulao smear test done for the screening of precancerous cervical lesions has been known to be effective in preventing the disease. The commonest types of cervical cancer are the cervical squamous cell carcinoma and adenocarcinoma.
Background
Every year there are 530,000 new cases of cervical cancer and an estimated 273,000 deaths from the disease worldwide making it the second most common cause of malignancy in females following breast cancer but the commonest of gynecological malignancy.
1, 2, 3 There are variations in the incidence and mortality of cervical cancer from country to country. 3 Eighty percent (80%) of the burden of this disease is in the developing countries with the women in developing countries having two to three times a higher incidence of cervical cancer and related mortality compared to those in developed countries.
3, 4, 5 The human papillomavirus (HPV) is an undeveloped double-stranded deoxyribonucleic acid (dsDNA) virus capable of infecting humans and inducing cervical cancer in females. 5 The Italian physician Rigoni -Stern in 1842 published a paper analyzing the death records in Verona from 1760 to 1839. He found that death from cancer of the uterus was common in married women and widows but rare in nuns and virgins which are associated with nulliparity and low parity. 6, 7, 8, 9 In 1907, Guiseppe Ciuffo discovered that skin and genital warts were associated with HPV infection. 8, 9 In 1934 Peyton Rous and colleague demonstrated that HPV and tar joint action consistently induced squamous cell carcinoma. 10, 11, 12 The sources of tar according to them is cigarette smoking, smoke from coal or wood burning or even from stoves. 8, 13 These viruses are capable of infecting immature squamous epithelium of the stratum germinativum (basal layer) which could be easily found in areas of squamous metaplasia in the squamocolumnar junction or following erosion of the cervix.
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Ninety percent of those infected are cleared of the infection within two years. 2 When the infection persists it may result in atypical koilocytic changes in the cervical epithelium.
2, 17 At this stage, cervical intraepithelial neoplasia is said to have developed and this could be detected with regular Papanicolaou smear screening. When cervical intraepithelial neoplasia is diagnosed, it could be treated accordingly thus preventing its progression into invasive cervical cancer. This has been largely responsible for the decline in the incidence of cervical carcinoma in developed countries such as the United States of America. 10, 25 Eighty percent of the low-grade squamous intraepithelial lesion (LSIL) and hundred percent of the high-grade squamous intraepithelial lesion (HSIL) are associated with high-risk HPV infections.
2 About forty percent of those with high-risk HPV infection would develop HSIL and of these, ten percent would progress to invasive cervical cancer within a period of ten years.
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In sub-Saharan Africa, the cervical cancer screening programme has a poor coverage. 18 A study done by Parkin et al in 2002 comparing the coverage of cervical cancer screening programmes in 57 countries showed an effective coverage of the cervical screening to be 40% on the average and in the 30 developing countries that were surveyed it was 19% on the average. 18 Similarly, a study by Louie et.al in 2009 stated the cervical cancer screening coverage in sub-Saharan Africa to be 2 to 20% in the urban areas and 0.4 to 14% in the rural areas. 19 Sixty to eighty percent (60 -80%) of the women who develop cervical cancer in sub-Saharan Africa live in the rural areas with no opportunity of taking part in a cervical screening programme. 20, 21, 22 Also, the cervical cancer screening programme has been found to have a better coverage among those of higher socio-economic class which still put the people of sub-Saharan Africa among those that would have poor coverage of the screening programme. 19 Similarly, a publication in the WHO bulletin from a study by Sankaranarayanan et al in 2001, showed that there are generally no organized cervical cancer screening programmes in sub-Saharan Africa. 25 With the foregoing, there is little wonder 80% of the burden of death from cervical cancer is in the developing countries. 10 On the other hand, studies have shown an increase in the proportion of adenocarcinoma of the cervix If this vaccine could be introduced into the national immunization programme, the ability to achieve a successful coverage like other vaccines in the programme is feasible.
The human papillomaviruses (HPV) which cause cervical cancer are non-enveloped viruses which possess icosahedral symmetry, 72 capsomers and doublestranded circular DNA genome with the nucleus as its site of replication. The viral genome is divided into an early region, which is necessary for neoplastic/malignant transformation; a late region, which codes for the capsid proteins; and a regulatory region which contains the origin of replication and control elements for transformation and replication. 22 There are eight open reading frames (E1 to E8) in the early region and two in the late region (L1 and L2), all of which are located on the same strand of DNA.
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Aetiopathogenesis of Cervical Carcinoma
The aetiologic agent responsible for causing cervical carcinoma is HPV. The high-risk oncogenic HPV is responsible for this malignant transformation in cervical epithelium. The virus infects immature squamous epithelium. This immature squamous epithelium can be found following erosion of the cervical epithelium exposing the immature cells or it may be from squamous metaplasia at the squamocolumnar junction of the cervix. When it infects the cell, the virus integrates its DNA into that of the cell and begins to produce oncoproteins E5, E6, E7 but E6 and E7 are usually responsible for the malignant transformation.
2, 10, 25 E6 Oncoprotein binds to p53 and stimulates ubiquitin-dependent proteolytic degradation of p53, thus interrupting the death pathway. E6 also up-regulates telomerase, preventing replicative senescence. Also, E7 binds to hypophosphorylated Rb protein, promoting its proteolytic degradation thus allowing E2F to freely stimulate transcription. E6 and E7 induce centromere duplication and genomic instability.
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These two Oncoproteins promote deoxyribonucleic acid (DNA) synthesis and interrupt p53 mediated apoptosis or cell growth arrest in mutant cells. These effects of these Oncoproteins result in malignant transformation of the cells. The integration of HPV virus into host DNA may be associated with chromosomal abnormalities. 10, 17 These HPV infections are sexually transmitted infections and the prevalence is higher in women who recently commenced sexual activity. It is commonly seen in women between the ages of 15 and 25years. 
